The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancer

Despite the use of front-line anticancer drugs such as paclitaxel for ovarian cancer treatment, mortality rates have remained almost unchanged for the past three decades and the majority of patients will develop recurrent chemoresistant disease which remains largely untreatable. Overcoming chemoresi...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:PLoS One
Prif Awduron: Bates, Mark, Spillane, Cathy D., Gallagher, Michael F., McCann, Amanda, Martin, Cara, Blackshields, Gordon, Keegan, Helen, Gubbins, Luke, Brooks, Robert, Brooks, Doug, Selemidis, Stavros, O’Toole, Sharon, O’Leary, John J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Public Library of Science 2020
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7769460/
https://ncbi.nlm.nih.gov/pubmed/33370338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0243715
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg